Quarter Period Consolidated Statement Of Comprehensive Income

Pharmarise Holdings Corporation - Filing #7289113

Concept 2024-06-01 to
2024-11-30
2023-06-01 to
2023-11-30
Quarter period consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
-121,000,000 JPY
282,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
JPY
2,000,000 JPY
Remeasurements of defined benefit plans, net of tax
-4,000,000 JPY
0 JPY
Other comprehensive income
-4,000,000 JPY
1,000,000 JPY
Comprehensive income
-125,000,000 JPY
283,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
-117,000,000 JPY
275,000,000 JPY
Comprehensive income attributable to non-controlling interests
-7,000,000 JPY
8,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.